Rhode Island H7188 caps insulin administration and glucose monitoring equipment/supplies costs at $25 per 30-day supply, effective January 1, 2027.
Rhode Island H7188 establishes a cap of $25 for the cost of equipment and supplies for insulin administration and glucose monitoring per 30-day supply, effective January 1, 2027. This cap applies to all health insurance policies in the state, excluding supplemental policies that only cover specified diseases. The cap does not apply to specific items before meeting the plan's deductible if it would make the policyholder ineligible for a health savings account.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.